Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01751750 · ClinicalTrials.gov registry record · NA
Grape Polyphenol Kinetics in Humans
A NA study, sponsored by Janet Novotny.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT01751750: Completed NA study, sponsored by Janet Novotny.
NCT01751750 is a NA study that has completed, run by Janet Novotny. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01751750, a NA study, has completed, sponsored by Janet Novotny.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The objectives of this study are the following: 1) to confirm that the administration of grape juice, resveratrol, and grape seed polyphenol extract results in a similar plasma and urinary metabolic profile in aged humans compared to rats, 2) to confirm that a combined administration of grape juice, resveratrol, and grape seed polyphenol extract result in a similar plasma and urinary metabolic profile in adults with tendencies toward metabolic syndrome compared to non-obese healthy humans, and 3) to identify the anti-inflammatory effects of the combined administration of grape juice, resveratrol, and grape seed polyphenol extract.
Interventions
- OTHER Grape
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2011-09 |
| Est. Completion | 2011-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01751750
The ClinicalTrials.gov registry entry for NCT01751750 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Janet Novotny, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Grape is the first listed.
NCT01751750 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01751750 about?
NCT01751750 is a clinical study titled "Grape Polyphenol Kinetics in Humans". The objectives of this study are the following: 1) to confirm that the administration of grape juice, resveratrol, and grape seed polyphenol extract results in a similar plasma and urinary metabolic profile in aged humans compared to rats, 2) to confirm that a combined administration of grape juice,...
What is the current status of trial NCT01751750?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2011-09. Estimated completion is 2011-09.
What interventions are being tested in trial NCT01751750?
The interventions under investigation include: Grape (OTHER).
Who is sponsoring clinical trial NCT01751750?
This trial is sponsored by Janet Novotny, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.